GARFIELD-AF – Initiation of Antiplatelet Therapy Plus Oral Anticoagulation for Newly-diagnosed Atrial Fibrillation is Associated with Worse Outcomes than Anticoagulation Alone
– Insight into the results of the GARFIELD-AF registry, presented at the European Society of Cardiology Congress, Munich, Germany, 25–29 August 2018 Evidence suggests that in patients with atrial fibrillation (AF) and myocardial infarction (MI), or in those undergoing percutaneous coronary intervention, the use of antiplatelet (AP) therapy with anticoagulation is beneficial.1 In these patients, […]